MYASTHAENIA GRAVIS
Clinical trials for MYASTHAENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHAENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHAENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a single mRNA treatment ease myasthenia gravis symptoms?
Disease control Recruiting nowThis phase 3 study tests an experimental therapy called Descartes-08 in 100 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The treatment uses mRNA to reprogram a patient's own immune cells to target and calm the overactive immune response. The…
Matched conditions: MYASTHAENIA GRAVIS
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
15-Year safety check for experimental CAR t therapy begins
Knowledge-focused Recruiting nowThis study tracks 70 people who have already received an infusion of KYV-101, a CAR T cell therapy, for autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to watch for delayed side effects, new cancers, or other health problems over up to 15…
Matched conditions: MYASTHAENIA GRAVIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC